Epigenetic Upregulation of lncRNAs at 13q14.3 in Leukemia Is Linked to the Downregulation of a Gene Cluster That Targets NF-kB

English version České info

Non-coding RNAs are much more common than previously thought. However, for the vast majority of non-coding RNAs, the cellular function remains enigmatic. The two long non-coding RNA (lncRNA) genes DLEU1 and DLEU2 map to a critical region at chromosomal band 13q14.3 that is recurrently deleted in solid tumors and hematopoietic malignancies like chronic lymphocytic leukemia (CLL). While no point mutations have been found in the protein coding candidate genes at 13q14.3, they are deregulated in malignant cells, suggesting an epigenetic tumor suppressor mechanism. We therefore characterized the epigenetic makeup of 13q14.3 in CLL cells and found histone modifications by chromatin-immunoprecipitation (ChIP) that are associated with activated transcription and significant DNA-demethylation at the transcriptional start sites of DLEU1 and DLEU2 using 5 different semi-quantitative and quantitative methods (aPRIMES, BioCOBRA, MCIp, MassARRAY, and bisulfite sequencing). These epigenetic aberrations were correlated with transcriptional deregulation of the neighboring candidate tumor suppressor genes, suggesting a coregulation in cis of this gene cluster. We found that the 13q14.3 genes in addition to their previously known functions regulate NF-kB activity, which we could show after overexpression, siRNA–mediated knockdown, and dominant-negative mutant genes by using Western blots with previously undescribed antibodies, by a customized ELISA as well as by reporter assays. In addition, we performed an unbiased screen of 810 human miRNAs and identified the miR-15/16 family of genes at 13q14.3 as the strongest inducers of NF-kB activity. In summary, the tumor suppressor mechanism at 13q14.3 is a cluster of genes controlled by two lncRNA genes that are regulated by DNA-methylation and histone modifications and whose members all regulate NF-kB. Therefore, the tumor suppressor mechanism in 13q14.3 underlines the role both of epigenetic aberrations and of lncRNA genes in human tumorigenesis and is an example of colocalization of a functionally related gene cluster.

Vyšlo v časopise: Epigenetic Upregulation of lncRNAs at 13q14.3 in Leukemia Is Linked to the Downregulation of a Gene Cluster That Targets NF-kB. PLoS Genet 9(4): e32767. doi:10.1371/journal.pgen.1003373
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pgen.1003373

Souhrn

Zdroje

1. HuarteM, RinnJL (2010) Large non-coding RNAs: missing links in cancer? Hum Mol Genet 19: R152–161.

2. MercerTR, DingerME, MattickJS (2009) Long non-coding RNAs: insights into functions. Nat Rev Genet 10: 155–159.

3. BartelDP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281–297.

4. PontingCP, OliverPL, ReikW (2009) Evolution and functions of long noncoding RNAs. Cell 136: 629–641.

5. NaganoT, FraserP (2011) No-nonsense functions for long noncoding RNAs. Cell 145: 178–181.

6. OromUA, DerrienT, BeringerM, GumireddyK, GardiniA, et al. (2010) Long noncoding RNAs with enhancer-like function in human cells. Cell 143: 46–58.

7. StilgenbauerS, NickolenkoJ, WilhelmJ, WolfS, WeitzS, et al. (1998) Expressed sequences as candidates for a novel tumor suppressor gene at band 13q14 in B-cell chronic lymphocytic leukemia and mantle cell lymphoma. Oncogene 16: 1891–1897.

8. WolfS, MertensD, SchaffnerC, KorzC, DohnerH, et al. (2001) B-cell neoplasia associated gene with multiple splicing (BCMS): the candidate B-CLL gene on 13q14 comprises more than 560 kb covering all critical regions. Hum Mol Genet 10: 1275–1285.

9. CorcoranMM, HammarsundM, ZhuC, LernerM, KapanadzeB, et al. (2004) DLEU2 encodes an antisense RNA for the putative bicistronic RFP2/LEU5 gene in humans and mouse. Genes Chromosomes Cancer 40: 285–297.

10. OuilletteP, ErbaH, KujawskiL, KaminskiM, SheddenK, et al. (2008) Integrated genomic profiling of chronic lymphocytic leukemia identifies subtypes of deletion 13q14. Cancer Res 68: 1012–1021.

11. LernerM, HaradaM, LovenJ, CastroJ, DavisZ, et al. (2009) DLEU2, frequently deleted in malignancy, functions as a critical host gene of the cell cycle inhibitory microRNAs miR-15a and miR-16-1. Exp Cell Res 315: 2941–2952.

12. Lagos-QuintanaM, RauhutR, LendeckelW, TuschlT (2001) Identification of novel genes coding for small expressed RNAs. Science 294: 853–858.

13. CalinGA, DumitruCD, ShimizuM, BichiR, ZupoS, et al. (2002) Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A 99: 15524–15529.

14. LiuY, CorcoranM, RasoolO, IvanovaG, IbbotsonR, et al. (1997) Cloning of two candidate tumor suppressor genes within a 10 kb region on chromosome 13q14, frequently deleted in chronic lymphocytic leukemia. Oncogene 15: 2463–2473.

15. RawstronAC, BennettFL, O'ConnorSJ, KwokM, FentonJA, et al. (2008) Monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia. N Engl J Med 359: 575–583.

16. KleinU, LiaM, CrespoM, SiegelR, ShenQ, et al. (2010) The DLEU2/miR-15a/16-1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia. Cancer Cell 17: 28–40.

17. RondeauG, MoreauI, BezieauS, CadoretE, MoisanJP, et al. (1999) Exclusion of Leu1 and Leu2 genes as tumor suppressor genes in 13q14.3-deleted B-CLL. Leukemia 13: 1630–1632.

18. OuilletteP, CollinsR, ShakhanS, LiJ, LiC, et al. (2011) The prognostic significance of various 13q14 deletions in chronic lymphocytic leukemia. Clin Cancer Res 17: 6778–6790.

19. LichterP (2010) All you need is a Mir-acle: the role of nontranslated RNAs in the suppression of B cell chronic lymphocytic leukemia. Cancer Cell 17: 3–4.

20. LiaM, CaretteA, TangH, ShenQ, MoT, et al. (2012) Functional dissection of the chromosome 13q14 tumor suppressor locus using transgenic mouse lines. Blood 119: 2981–2990.

21. BrownJR, LawrenceMS, HannaM, TesarB, StojanovP, et al. (2011) Novel Germline Genetic Variants Associated with Familial Chronic Lymphocytic Leukemia (CLL). ASH Annual Meeting Abstracts 118: 465-.

22. CalinGA, FerracinM, CimminoA, Di LevaG, ShimizuM, et al. (2005) A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med 353: 1793–1801.

23. RavecheES, SalernoE, ScaglioneBJ, ManoharV, AbbasiF, et al. (2007) Abnormal microRNA-16 locus with synteny to human 13q14 linked to CLL in NZB mice. Blood 109: 5079–5086.

24. AllegraD, MertensD (2011) In-vivo quantification of primary microRNA processing by Drosha with a luciferase based system. Biochem Biophys Res Commun 406: 501–505.

25. MigliazzaA, BoschF, KomatsuH, CayanisE, MartinottiS, et al. (2001) Nucleotide sequence, transcription map, and mutation analysis of the 13q14 chromosomal region deleted in B-cell chronic lymphocytic leukemia. Blood 97: 2098–2104.

26. MertensD, WolfS, SchroeterP, SchaffnerC, DohnerH, et al. (2002) Down-regulation of candidate tumor suppressor genes within chromosome band 13q14.3 is independent of the DNA methylation pattern in B-cell chronic lymphocytic leukemia. Blood 99: 4116–4121.

27. FulciV, ChiarettiS, GoldoniM, AzzalinG, CarucciN, et al. (2007) Quantitative technologies establish a novel microRNA profile of chronic lymphocytic leukemia. Blood 109: 4944–4951.

28. RavalA, TannerSM, ByrdJC, AngermanEB, PerkoJD, et al. (2007) Downregulation of death-associated protein kinase 1 (DAPK1) in chronic lymphocytic leukemia. Cell 129: 879–890.

29. ChenSS, RavalA, JohnsonAJ, HertleinE, LiuTH, et al. (2009) Epigenetic changes during disease progression in a murine model of human chronic lymphocytic leukemia. Proc Natl Acad Sci U S A 106: 13433–13438.

30. XieX, MikkelsenTS, GnirkeA, Lindblad-TohK, KellisM, et al. (2007) Systematic discovery of regulatory motifs in conserved regions of the human genome, including thousands of CTCF insulator sites. Proc Natl Acad Sci U S A 104: 7145–7150.

31. KapanadzeB, MakeevaN, CorcoranM, JareborgN, HammarsundM, et al. (2000) Comparative sequence analysis of a region on human chromosome 13q14, frequently deleted in B-cell chronic lymphocytic leukemia, and its homologous region on mouse chromosome 14. Genomics 70: 327–334.

32. BunzelR, BlumckeI, CichonS, NormannS, SchrammJ, et al. (1998) Polymorphic imprinting of the serotonin-2A (5-HT2A) receptor gene in human adult brain. Brain Res Mol Brain Res 59: 90–92.

33. KanberD, BerulavaT, AmmerpohlO, MitterD, RichterJ, et al. (2009) The human retinoblastoma gene is imprinted. PLoS Genet 5: e1000790 doi:10.1371/journal.pgen.1000790.

34. MertensD, PhilippenA, RuppelM, AllegraD, BhattacharyaN, et al. (2009) Chronic lymphocytic leukemia and 13q14: miRs and more. Leuk Lymphoma 50: 502–505.

35. MertensD, WolfS, TschuchC, MundC, KienleD, et al. (2006) Allelic silencing at the tumor-suppressor locus 13q14.3 suggests an epigenetic tumor-suppressor mechanism. Proc Natl Acad Sci U S A 103: 7741–7746.

36. LehmannS, OgawaS, RaynaudSD, SanadaM, NannyaY, et al. (2008) Molecular allelokaryotyping of early-stage, untreated chronic lymphocytic leukemia. Cancer 112: 1296–1305.

37. StilgenbauerS, SanderS, BullingerL, BennerA, LeupoltE, et al. (2007) Clonal evolution in chronic lymphocytic leukemia: acquisition of high-risk genomic aberrations associated with unmutated VH, resistance to therapy, and short survival. Haematologica 92: 1242–1245.

38. CuniS, Perez-AciegoP, Perez-ChaconG, VargasJA, SanchezA, et al. (2004) A sustained activation of PI3K/NF-kappaB pathway is critical for the survival of chronic lymphocytic leukemia B cells. Leukemia 18: 1391–1400.

39. HerishanuY, Perez-GalanP, LiuD, BiancottoA, PittalugaS, et al. (2010) The lymph node microenvironment promotes B-cell receptor signaling, NF-kappaB activation, and tumor proliferation in chronic lymphocytic leukemia. Blood 117: 563–574.

40. VallatLD, ParkY, LiC, GribbenJG (2007) Temporal genetic program following B-cell receptor cross-linking: altered balance between proliferation and death in healthy and malignant B cells. Blood 109: 3989–3997.

41. FrommerM, McDonaldLE, MillarDS, CollisCM, WattF, et al. (1992) A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc Natl Acad Sci U S A 89: 1827–1831.

42. EhrichM, NelsonMR, StanssensP, ZabeauM, LiloglouT, et al. (2005) Quantitative high-throughput analysis of DNA methylation patterns by base-specific cleavage and mass spectrometry. Proc Natl Acad Sci U S A 102: 15785–15790.

43. BrenaRM, AuerH, KornackerK, PlassC (2006) Quantification of DNA methylation in electrofluidics chips (Bio-COBRA). Nat Protoc 1: 52–58.

44. SchillingE, RehliM (2007) Global, comparative analysis of tissue-specific promoter CpG methylation. Genomics 90: 314–323.

45. PfisterS, SchlaegerC, MendrzykF, WittmannA, BennerA, et al. (2007) Array-based profiling of reference-independent methylation status (aPRIMES) identifies frequent promoter methylation and consecutive downregulation of ZIC2 in pediatric medulloblastoma. Nucleic Acids Res 35: e51.

46. HammarsundM, CorcoranMM, WilsonW, ZhuC, EinhornS, et al. (2004) Characterization of a novel B-CLL candidate gene–DLEU7–located in the 13q14 tumor suppressor locus. FEBS Lett 556: 75–80.

47. BernsteinBE, HumphreyEL, ErlichRL, SchneiderR, BoumanP, et al. (2002) Methylation of histone H3 Lys 4 in coding regions of active genes. Proc Natl Acad Sci U S A 99: 8695–8700.

48. GambleMJ, FrizzellKM, YangC, KrishnakumarR, KrausWL (2010) The histone variant macroH2A1 marks repressed autosomal chromatin, but protects a subset of its target genes from silencing. Genes Dev 24: 21–32.

49. BarretoG, SchaferA, MarholdJ, StachD, SwaminathanSK, et al. (2007) Gadd45a promotes epigenetic gene activation by repair-mediated DNA demethylation. Nature 445: 671–675.

50. AuerRL, RiazS, CotterFE (2007) The 13q and 11q B-cell chronic lymphocytic leukaemia-associated regions derive from a common ancestral region in the zebrafish. Br J Haematol 137: 443–453.

51. ZenzT, MertensD, KuppersR, DohnerH, StilgenbauerS (2010) From pathogenesis to treatment of chronic lymphocytic leukaemia. Nat Rev Cancer 10: 37–50.

52. BullrichF, FujiiH, CalinG, MabuchiH, NegriniM, et al. (2001) Characterization of the 13q14 tumor suppressor locus in CLL: identification of ALT1, an alternative splice variant of the LEU2 gene. Cancer Res 61: 6640–6648.

53. SampathD, LiuC, VasanK, SuldaM, PuduvalliVK, et al. (2012) Histone deacetylases mediate the silencing of miR-15a, miR-16 and miR-29b in chronic lymphocytic leukemia. Blood 119: 1162–1172.

54. BellAC, WestAG, FelsenfeldG (1999) The protein CTCF is required for the enhancer blocking activity of vertebrate insulators. Cell 98: 387–396.

55. De La Rosa-VelazquezIA, Rincon-AranoH, Benitez-BribiescaL, Recillas-TargaF (2007) Epigenetic regulation of the human retinoblastoma tumor suppressor gene promoter by CTCF. Cancer Res 67: 2577–2585.

56. MondalT, RasmussenM, PandeyGK, IsakssonA, KanduriC (2010) Characterization of the RNA content of chromatin. Genome Res 20: 899–907.

57. BonciD, CoppolaV, MusumeciM, AddarioA, GiuffridaR, et al. (2008) The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities. Nat Med 14: 1271–1277.

58. LiuQ, FuH, SunF, ZhangH, TieY, et al. (2008) miR-16 family induces cell cycle arrest by regulating multiple cell cycle genes. Nucleic Acids Res 36: 5391–5404.

59. LinsleyPS, SchelterJ, BurchardJ, KibukawaM, MartinMM, et al. (2007) Transcripts targeted by the microRNA-16 family cooperatively regulate cell cycle progression. Mol Cell Biol 27: 2240–2252.

60. RoccaroAM, SaccoA, ThompsonB, LeleuX, AzabAK, et al. (2009) MicroRNAs 15a and 16 regulate tumor proliferation in multiple myeloma. Blood 113: 6669–6680.

61. PalamarchukA, EfanovA, NazaryanN, SantanamU, AlderH, et al. (2010) 13q14 deletions in CLL involve cooperating tumor suppressors. Blood 115: 3916–3922.

62. TorokI, StrandD, SchmittR, TickG, TorokT, et al. (1995) The overgrown hematopoietic organs-31 tumor suppressor gene of Drosophila encodes an Importin-like protein accumulating in the nucleus at the onset of mitosis. J Cell Biol 129: 1473–1489.

63. FagerlundR, KinnunenL, KohlerM, JulkunenI, MelenK (2005) NF-{kappa}B is transported into the nucleus by importin {alpha}3 and importin {alpha}4. J Biol Chem 280: 15942–15951.

64. KeklikoglouI, KoernerC, SchmidtC, ZhangJD, HeckmannD, et al. (2012) MicroRNA-520/373 family functions as a tumor suppressor in estrogen receptor negative breast cancer by targeting NF-kappaB and TGF-beta signaling pathways. Oncogene 31: 4150–4163.

65. BandiN, ZbindenS, GuggerM, ArnoldM, KocherV, et al. (2009) miR-15a and miR-16 are implicated in cell cycle regulation in a Rb-dependent manner and are frequently deleted or down-regulated in non-small cell lung cancer. Cancer Res 69: 5553–5559.

66. LiT, MorganMJ, ChoksiS, ZhangY, KimYS, et al. (2010) MicroRNAs modulate the noncanonical transcription factor NF-kappaB pathway by regulating expression of the kinase IKKalpha during macrophage differentiation. Nat Immunol 11: 799–805.

67. ZhouR, LiX, HuG, GongAY, DrescherKM, et al. (2012) miR-16 targets transcriptional corepressor SMRT and modulates NF-kappaB-regulated transactivation of interleukin-8 gene. PLoS ONE 7: e30772 doi:10.1371/journal.pone.0030772.

68. HongS, LeeC, KimSJ (2007) Smad7 sensitizes tumor necrosis factor induced apoptosis through the inhibition of antiapoptotic gene expression by suppressing activation of the nuclear factor-kappaB pathway. Cancer Res 67: 9577–9583.

69. MatsudaA, SuzukiY, HondaG, MuramatsuS, MatsuzakiO, et al. (2003) Large-scale identification and characterization of human genes that activate NF-kappaB and MAPK signaling pathways. Oncogene 22: 3307–3318.

70. LernerM, CorcoranM, CepedaD, NielsenML, ZubarevR, et al. (2007) The RBCC gene RFP2 (Leu5) encodes a novel transmembrane E3 ubiquitin ligase involved in ERAD. Mol Biol Cell 18: 1670–1682.

71. BhattacharyaN, SarnoA, IdlerIS, FuhrerM, ZenzT, et al. (2010) High-throughput detection of nuclear factor-kappaB activity using a sensitive oligo-based chemiluminescent enzyme-linked immunosorbent assay. Int J Cancer 127: 404–411.

72. TomarD, SinghR, SinghAK, PandyaCD (2012) TRIM13 regulates ER stress induced autophagy and clonogenic ability of the cells. Biochim Biophys Acta 1823: 316–326.

73. DaroszewskaA, RalstonSH (2005) Genetics of Paget's disease of bone. Clin Sci (Lond) 109: 257–263.

74. McManusS, RouxS (2012) The adaptor protein p62/SQSTM1 in osteoclast signaling pathways. J Mol Signal 7: 1.

75. ReymondA, MeroniG, FantozziA, MerlaG, CairoS, et al. (2001) The tripartite motif family identifies cell compartments. Embo J 20: 2140–2151.

76. StachD, SchmitzOJ, StilgenbauerS, BennerA, DohnerH, et al. (2003) Capillary electrophoretic analysis of genomic DNA methylation levels. Nucleic Acids Res 31: E2.

77. HeY, VogelsteinB, VelculescuVE, PapadopoulosN, KinzlerKW (2008) The antisense transcriptomes of human cells. Science 322: 1855–1857.

78. FlynnRA, ChangHY (2012) Active chromatin and noncoding RNAs: an intimate relationship. Curr Opin Genet Dev 22: 172–178.

79. FaghihiMA, WahlestedtC (2009) Regulatory roles of natural antisense transcripts. Nat Rev Mol Cell Biol 10: 637–643.

80. SmitsG, MungallAJ, Griffiths-JonesS, SmithP, BeuryD, et al. (2008) Conservation of the H19 noncoding RNA and H19-IGF2 imprinting mechanism in therians. Nat Genet 40: 971–976.

81. ZhangX, LianZ, PaddenC, GersteinMB, RozowskyJ, et al. (2009) A myelopoiesis-associated regulatory intergenic noncoding RNA transcript within the human HOXA cluster. Blood 113: 2526–2534.

82. TreppendahlMB, QiuX, SogaardA, YangX, Nandrup-BusC, et al. (2012) Allelic methylation levels of the noncoding VTRNA2-1 located on chromosome 5q31.1 predict outcome in AML. Blood 119: 206–216.

83. DallossoAR, HancockAL, MalikS, SalpekarA, King-UnderwoodL, et al. (2007) Alternately spliced WT1 antisense transcripts interact with WT1 sense RNA and show epigenetic and splicing defects in cancer. RNA 13: 2287–2299.

84. StolcV, GauharZ, MasonC, HalaszG, van BatenburgMF, et al. (2004) A gene expression map for the euchromatic genome of Drosophila melanogaster. Science 306: 655–660.

85. SproulD, GilbertN, BickmoreWA (2005) The role of chromatin structure in regulating the expression of clustered genes. Nat Rev Genet 6: 775–781.

86. SiebenlistU, BrownK, ClaudioE (2005) Control of lymphocyte development by nuclear factor-kappaB. Nat Rev Immunol 5: 435–445.

87. HewamanaS, AlghazalS, LinTT, ClementM, JenkinsC, et al. (2008) The NF-kappaB subunit Rel A is associated with in vitro survival and clinical disease progression in chronic lymphocytic leukemia and represents a promising therapeutic target. Blood 111: 4681–4689.

88. GaudioE, SpizzoR, PaduanoF, LuoZ, EfanovA, et al. (2012) Tcl1 interacts with Atm and enhances NF-kappaB activation in hematologic malignancies. Blood 119: 180–187.

89. GardingA, BhattacharyaN, HaebeS, MuellerF, WeichenhanD, et al. (2013) TCL1A and ATM are coexpressed in chronic lymphocytic leukemia cells without deletion of 11q. Haematologica 98: 269–273.

90. QuesadaV, CondeL, VillamorN, OrdonezGR, JaresP, et al. (2011) Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia. Nat Genet 44: 47–52.

91. WangL, LawrenceMS, WanY, StojanovP, SougnezC, et al. (2011) SF3B1 and other novel cancer genes in chronic lymphocytic leukemia. N Engl J Med 365: 2497–2506.

92. SchattnerEJ (2000) CD40 ligand in CLL pathogenesis and therapy. Leuk Lymphoma 37: 461–472.

93. KernC, CornuelJF, BillardC, TangR, RouillardD, et al. (2004) Involvement of BAFF and APRIL in the resistance to apoptosis of B-CLL through an autocrine pathway. Blood 103: 679–688.

94. EdelmannJ, Klein-HitpassL, CarpinteiroA, FuhrerA, SellmannL, et al. (2008) Bone marrow fibroblasts induce expression of PI3K/NF-kappaB pathway genes and a pro-angiogenic phenotype in CLL cells. Leuk Res 32: 1565–1572.

95. JimiE, StricklandI, VollRE, LongM, GhoshS (2008) Differential role of the transcription factor NF-kappaB in selection and survival of CD4+ and CD8+ thymocytes. Immunity 29: 523–537.

96. ChiorazziN, RaiKR, FerrariniM (2005) Chronic lymphocytic leukemia. N Engl J Med 352: 804–815.

97. HewamanaS, LinTT, JenkinsC, BurnettAK, JordanCT, et al. (2008) The novel nuclear factor-kappaB inhibitor LC-1 is equipotent in poor prognostic subsets of chronic lymphocytic leukemia and shows strong synergy with fludarabine. Clin Cancer Res 14: 8102–8111.

98. Escobar-DiazE, Lopez-MartinEM, Hernandez del CerroM, Puig-KrogerA, Soto-CerratoV, et al. (2005) AT514, a cyclic depsipeptide from Serratia marcescens, induces apoptosis of B-chronic lymphocytic leukemia cells: interference with the Akt/NF-kappaB survival pathway. Leukemia 19: 572–579.

99. BichiR, ShintonSA, MartinES, KovalA, CalinGA, et al. (2002) Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression. Proc Natl Acad Sci U S A 99: 6955–6960.

100. KikushigeY, IshikawaF, MiyamotoT, ShimaT, UrataS, et al. (2011) Self-renewing hematopoietic stem cell is the primary target in pathogenesis of human chronic lymphocytic leukemia. Cancer Cell 20: 246–259.

101. KlugM, RehliM (2006) Functional analysis of promoter CpG methylation using a CpG-free luciferase reporter vector. Epigenetics 1: 127–130.

102. BrenaRM, AuerH, KornackerK, HackansonB, RavalA, et al. (2006) Accurate quantification of DNA methylation using combined bisulfite restriction analysis coupled with the Agilent 2100 Bioanalyzer platform. Nucleic Acids Res 34: e17.

103. GebhardC, SchwarzfischerL, PhamTH, SchillingE, KlugM, et al. (2006) Genome-wide profiling of CpG methylation identifies novel targets of aberrant hypermethylation in myeloid leukemia. Cancer Res 66: 6118–6128.

104. Caudron-HergerM, Muller-OttK, MallmJP, MarthC, SchmidtU, et al. (2011) Coding RNAs with a non-coding function: maintenance of open chromatin structure. Nucleus 2: 410–424.

105. KimDH, LongoM, HanY, LundbergP, CantinE, et al. (2004) Interferon induction by siRNAs and ssRNAs synthesized by phage polymerase. Nat Biotechnol 22: 321–325.